NCT01190930 arm group 21d5db319417cfceaa66905ec2eb4880 [clinicaltrials_resource:NCT01190930/arm-group/21d5db319417cfceaa66905ec2eb4880]
Mercaptopurine [clinicaltrials_resource:6ae78725206ef61714c204a7b9376073]Dexamethasone [clinicaltrials_resource:95f289cacdb1dc9b9dcdc784e5466e48]Quality-of-Life Assessment [clinicaltrials_resource:a2c49c8d41dbda899df8be9bb923f6d0]Methotrexate [clinicaltrials_resource:b3746bc72d0aa1704c850940391a5d90]Vincristine Sulfate [clinicaltrials_resource:b89e99861d2bd2a484b79920e6c694d7]Questionnaire Administration [clinicaltrials_resource:c78123a00577d26c6228e23d3f262b36]Laboratory Biomarker Analysis [clinicaltrials_resource:f94cf672917f339a5cf0d4cdba7ec94b]clinicaltrials:NCT01190930
arm group [clinicaltrials_vocabulary:arm-group]
NCT01190930 arm group 21d5db319417cfceaa66905ec2eb4880 [clinicaltrials_resource:NCT01190930/arm-group/21d5db319417cfceaa66905ec2eb4880]
Bio2RDF identifier
NCT01190930/arm-group/21d5db319417cfceaa66905ec2eb4880
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... d5db319417cfceaa66905ec2eb4880
description [clinicaltrials_vocabulary:description]
Patients receive vincristine s ...... and IT methotrexate on day 1.
identifier
clinicaltrials_resource:NCT01190930/arm-group/21d5db319417cfceaa66905ec2eb4880
title
NCT01190930 arm group 21d5db319417cfceaa66905ec2eb4880
@en
type
label
NCT01190930 arm group 21d5db31 ...... 5db319417cfceaa66905ec2eb4880]
@en